OP0154 Manocept, A Derivative of FDA-Approved 99MTC-Tilmanocept, Exhibits Diagnostic Potential by Specifically Identifying Macrophages in Rheumatoid Arthritis: A Novel Application of an Existing Drug
OP0154 Manocept, A Derivative of FDA-Approved 99MTC-Tilmanocept, Exhibits Diagnostic Potential by Specifically Identifying Macrophages in Rheumatoid Arthritis: A Novel Application of an Existing Drug